Upjohn Co.: The Kalamazoo, Mich., drug company...
Upjohn Co.: The Kalamazoo, Mich., drug company said third-quarter earnings rose 7% to $96 million. Revenue was up 10% to $717 million. The company noted that operating costs and expenses were down as a result of cost-containment measures and that pharmaceutical sales in the United States benefited significantly from previously announced price increases on several major products.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
